VICI Properties Inc (VICI) Stock Price Today
Aura AI Summary
Key Stats
- $28.95BMarket Cap
- -Volume
- Real EstateSector
- $33.7852W High
- $25.9152W Low
- -Typical Hold Time
- $46.50BEnterprise Value
- 6.85%Div Yield
- -Trading Activity
Track VICI Properties Inc (VICI) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, VICI Properties Inc has traded between a low of $25.91 and a high of $33.78, highlighting its annual price range. Buy and sell VICI Properties Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About VICI Properties Inc
VICI Properties is an S&P 500 experiential real estate investment trust (REIT) that owns one of the largest portfolios of market-leading gaming, hospitality, and entertainment destinations, including Caesars Palace and MGM Grand. It utilizes a long-term, triple-net lease model to provide stable, inflation-protected income, serving as the primary landlord for the 'experience economy' while diversifying into non-gaming sectors like wellness, youth sports, and luxury resorts.
Most Recent News
Credit card balances overdue by 90 days have nearly doubled since 2022, while new delinquencies remain steady.
Since 2022, the amount of credit card debt that is 90 days overdue has almost doubled, indicating growing financial stress among borrowers. However, the rate of new delinquencies has not increased, suggesting that while existing overdue balances are ...
Sintana Energy boosts cash to $15.5M, advancing Atlantic Margin projects with key drilling planned.
Sintana Energy increased its cash reserves to $15.5 million by June 2026, following an $11.5 million fundraising in May and remains debt-free with additional credit facilities. The company is progressing its Atlantic Margin exploration with upcoming ...
AstraZeneca's drug Tezspire succeeds in trial for swallowing disorder eosinophilic esophagitis.
AstraZeneca announced that its drug Tezspire met all primary and key secondary goals in a late-stage trial for eosinophilic esophagitis, a chronic condition causing inflammation and difficulty swallowing. The trial involved 368 patients who received ...
People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.